Dementia and Atrial Fibrillation: Pathophysiological Mechanisms and Therapeutic Implications

Area of Science:

• Neurology
• Cardiology
• Gerontology

Background:

• Atrial fibrillation (AF) is a major risk factor for stroke, increasing risk four- to fivefold.
• Dementia is a common consequence of stroke, but AF is also linked to cognitive impairment and dementia independently of overt stroke.
• Potential nonischemic mechanisms include cerebral hypoperfusion, inflammation, brain atrophy, genetic factors, and shared risk factors like hypertension.

Purpose of the Study:

• To critically appraise studies on the association between atrial fibrillation and dementia in stroke-free patients.
• To investigate the role of silent strokes and anticoagulation therapy in this relationship.
• To understand the multifactorial pathogenesis linking atrial fibrillation to dementia.

Main Methods:

• Critical appraisal of existing literature on atrial fibrillation and dementia in stroke-free populations.
• Analysis of methodological limitations in previous studies, including the exclusion of silent stroke and anticoagulation data.
• Review of evidence on nonischemic mechanisms and the impact of anticoagulation.

Main Results:

• Methodological issues were identified in several studies evaluating AF and dementia in stroke-free patients.
• A significant association exists between atrial fibrillation and dementia, often mediated by silent strokes even without overt clinical stroke.
• Anticoagulation therapy shows promise in reducing dementia risk for patients with atrial fibrillation.

Conclusions:

• The link between atrial fibrillation and dementia is multifactorial, with cerebral infarctions, including silent strokes, playing a key role.
• Effective stroke prevention strategies are crucial for managing dementia risk in atrial fibrillation patients.
• Further research addressing methodological limitations is needed to fully elucidate the AF-dementia relationship.